Casdin Capital, LLC 13D/13G Filings for Neurogene Inc. (NGNE)

Casdin Capital, LLC 13D and 13G filings for Neurogene Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
4:00 pm
Purchase		 2024-12-31 13G Neurogene Inc.
NGNE		 Casdin Capital, LLC 1,295,361
8.700%		 270,745increase
(+26.42%)		 Filing
2024-11-08
4:33 pm
Purchase		 2024-11-04 13G Neurogene Inc.
NGNE		 Casdin Capital, LLC 1,024,616
6.900%		 1,024,616increase
(New Position)		 Filing